Your CDMO Partner
for
We develop and manufacture your biopharmaceutical drug candidate – reliably and rapidly. Our innovative technologies can elevate your product to the highest yield, potency, quality, and safety levels.
Recap Webinar: Managing (Multiple) Complex Molecules in CDMO Projects
Thanks for your interest in latest our webinar, exploring the success factors for contract development and manufacturing organization (CDMO) projects with multiple complex molecules.
Our three experts from ProBioGen shared their insights and experiences and revealed the 5 key credentials for successful projects with (multiple) complex molecules.
These key credentials when managing (multiple) complex molecules in CDMO prejects are :
- Close partnership with the customer and excellent upfront alignment
- Highest level of scientific expertise and experience with respective molecules and variants
- Robust and flexible platform processes and special technologies
- Integrated in-house processes and well-coordinated teams
- Strong analytical method development and testing capabilities – early on
If you want to take another look into the webinar or unfortunately missed a part - do not worry. The recording of the webinar is now available!
Get in Touch with an Webinar Expert
Dr. Ellen Hilgenberg
ProBioGen - Your Integrated CDMO and Technology Expert for Biologics and Advanced Therapies
ProBioGen is a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines with applying proprietary technologies to improve product quality and features. Combining both state-of-the-art development services, together with intelligent product-specific technologies yields biologics with optimized properties. Rapid and integrated cell line and process development, comprehensive analytical development and GMP-compliant manufacturing is performed by a highly skilled and experienced team.
Our Integrated Services for Proteins and Viral Vectors
Whether you want to produce an (complex) antibody, a therapeutic protein, or a virus, ProBioGen is your trusted and highly experienced partner for development and manufacturing. Starting with unique cell lines and all the way to scalable production, our process is tailored to your individual requirements. Expect best-in-class efficiency and competitive timelines combined with excellent customer service.
Cell Line Development
Process Development (USP/DSP)
GMP Manufacturing
Virus Production
Analytics & Bioassays
Biosimilars & Biobetters
Stellar Technologies
Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.
Genetic Glyco-Engineering / ADCC (GlymaxX®)
DirectedLuck® Transposase with Epigenetic Targeting
Give your protein a ride on a cellular engine.
Lenti.RiGHT® Packaging and Producer Cell Line
Enables a scalable production of high-titer lentiviral particles for gene transfer applications.
Viral Vector Technologies
ProBioGen´s MVA platform - the most efficient production system for a potent vaccine vector.
Productivity Increase
One gene to boost them all - see how you can optimize your titers with our proven Pathway Modulator.
Virus Production Cell Lines
A scalable cell loine is the bedrock of industrial production. See what our high-yield lines do for your virus or vector.
Discover The Essence of ProBioGen
"Because of ProBioGen´s continous support and always providing valuable information not only on technical challenges but also urgent issues associated with the project, our teams were able to bring aproduct from facility tinto the clinic as scheduled, within several months here in Japan."
Chiome Bioscience Inc.
Director, CMC Development
"In ProBioGen, we see a company that values scientific contribution and enables high quality drug development for customers, which ultimately benefits the patients we all serve."
Celgene Corporation
Senior Director, Biologics Development
"In the midest of an escalating pandemic, ProBioGen successfully managed safety, staffing and procurement to maintain agressive timelines for Pionyr´s two first-in-class TME directed afucosylated monoclonal antibodies."
Pionyr Immunotherapeutics, Inc.
SVP, Technical Operations
Explore Related Content
ProBioGen AG
Follow us on: